Press release
Bronchitis Treatment Market Size Report 2032: Major Companies, Emerging Drugs, Clinical Trials, MOA, FDA Approvals | DelveInsight
Bronchitis Treatment Market Size
Discover Key Insights into the Bronchitis Market with DelveInsight's In-Depth Report @ Bronchitis Market Size- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Bronchitis Market Report
• In July 2025, Korea Arlico Pharm. Co. Ltd announced a phase 2 Clinical Trial to Evaluate the Efficacy and Safety of ALC-2203 in Patients with Acute Bronchitis.
• In July 2025, Incyte Corporation conducted a study will be conducted to evaluate the safety, efficacy, and pharmacokinetics of axatilimab monotherapy in Chinese participants with recurrent or refractory active chronic graft-versus-host disease after systemic therapy.
• In the 7MM, there were 19,517,000 cases of acute bronchitis in children and 29,174,000 cases in adults in 2022. During the predicted period, these cases are expected to rise
• Out of all the 7MM countries, Japan accounted for the least number of cases of chronic bronchitis, which formed ~4% of the total cases of chronic bronchitis in the 7MM
• In Germany, there were 1,574,000 cases of acute bronchitis in children and 2,819,000 cases in adults in 2022, respectively. During the predicted period, it is expected that these cases will rise
• In the 7MM in 2022, there were determined to be 26,954,000 instances of chronic bronchitis. By 2032, these cases are anticipated to rise
• Among the EU4, the UK, and France, acute bronchitis cases overall were found to be the highest. In 2022, these cases accounted for 47% of all cases of acute bronchitis in the EU4 and the UK
• Bronchitis Companies such as Hanlim Pharm. Co., Ltd, Ahn-Gook Pharmaceuticals Co.,Ltd, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm. Inc., Hyundai Pharmaceutical Co., LTD., Ahn-Gook Pharma, Bayer, Wake Forest University, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, and others
• Bronchitis Therapies such as HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox (Moxifloxacin, BAY12-8039), Oral N-acetycystein (NAC), Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8, and others
Stay ahead in the Bronchitis Therapeutics Market with DelveInsight's Strategic Report @ Bronchitis Market Outlook- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Epidemiology Segmentation in the 7MM
• Total Prevalence of Bronchitis
• Prevalent Cases of Bronchitis by severity
• Gender-specific Prevalence of Bronchitis
• Diagnosed Cases of Episodic and Chronic Bronchitis
Download the report to understand which factors are driving Bronchitis epidemiology trends @ Bronchitis Prevalence- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Bronchitis market or expected to get launched during the study period. The analysis covers Bronchitis market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
Bronchitis Therapies and Companies
• HL301: Hanlim Pharm. Co., Ltd
• AGS: Ahn-Gook Pharmaceuticals Co.,Ltd
• N02RS1: PharmaKing
• levofloxacin: Johnson & Johnson
• YHD001: Yuhan Corporation
• KALOMINTM: Korea United Pharm. Inc.
• Acebrophylline: Hyundai Pharmaceutical Co., LTD.
• Synatura®: Ahn-Gook Pharma
• Avelox (Moxifloxacin, BAY12-8039): Bayer
• Oral N-acetycystein (NAC): Wake Forest University
• Moxifloxacin: Pfizer
• telithromycin: Sanofi
• TPI 1020: Pharmaxis
• Emeramide: EmeraMed
• ABX-IL8: Abgenix
Get In-Depth Knowledge on Bronchitis Market Trends and Forecasts with DelveInsight @ Bronchitis Treatment Market- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Bronchitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM
• Bronchitis Companies: Hanlim Pharm. Co., Ltd, Ahn-Gook Pharmaceuticals Co.,Ltd, PharmaKing, Johnson & Johnson, Yuhan Corporation, Korea United Pharm. Inc., Hyundai Pharmaceutical Co., LTD., Ahn-Gook Pharma, Bayer, Wake Forest University, Pfizer, Sanofi, Pharmaxis, EmeraMed, Abgenix, and others
• Bronchitis Therapies: HL301, AGS, N02RS1, levofloxacin, YHD001, KALOMINTM, Acebrophylline, Synatura®, Avelox (Moxifloxacin, BAY12-8039), Oral N-acetycystein (NAC), Moxifloxacin, telithromycin, TPI 1020, Emeramide, ABX-IL8, and others
• Bronchitis Therapeutic Assessment: Bronchitis current marketed and Bronchitis emerging therapies
• Bronchitis Market Dynamics: Bronchitis market drivers and Bronchitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Bronchitis Unmet Needs, KOL's views, Analyst's views, Bronchitis Market Access and Reimbursement
Unlock Strategic Insights with DelveInsight's Comprehensive Bronchitis Market Report @ Bronchitis Market Drivers and Barriers- https://www.delveinsight.com/sample-request/bronchitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Bronchitis Market Report Introduction
2. Executive Summary for Bronchitis
3. SWOT analysis of Bronchitis
4. Bronchitis Patient Share (%) Overview at a Glance
5. Bronchitis Market Overview at a Glance
6. Bronchitis Disease Background and Overview
7. Bronchitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Bronchitis
9. Bronchitis Current Treatment and Medical Practices
10. Bronchitis Unmet Needs
11. Bronchitis Emerging Therapies
12. Bronchitis Market Outlook
13. Country-Wise Bronchitis Market Analysis (2019-2032)
14. Bronchitis Market Access and Reimbursement of Therapies
15. Bronchitis Market Drivers
16. Bronchitis Market Barriers
17. Bronchitis Appendix
18. Bronchitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchitis Treatment Market Size Report 2032: Major Companies, Emerging Drugs, Clinical Trials, MOA, FDA Approvals | DelveInsight here
News-ID: 4124880 • Views: …
More Releases from DelveInsight Business Research LLP
Gonorrhoea Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Tri …
DelveInsight's "Gonorrhoea Pipeline Insight 2025" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in the Gonorrhoea pipeline landscape. It covers the Gonorrhoea pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Gonorrhoea pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Gonorrhoea pipeline products in this space.
Explore our latest breakthroughs in Gonorrhoea Research. Learn…
Glioblastoma Multiforme Market Size (7MM) was ~USD 835 million in 2023 and is ex …
DelveInsight's "Glioblastoma Multiforme Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of GBM, historical and forecasted epidemiology as well as the GBM market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover Key Insights into the Glioblastoma Multiforme Market with DelveInsight's In-Depth Report @ Glioblastoma Multiforme Market Size- https://www.delveinsight.com/sample-request/glioblastoma-multiforme-gbm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Glioblastoma Multiforme Market Report
• In…
Blepharitis Treatment Market Size in the 7MM is expected to grow by 2034, estima …
DelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Blepharitis, historical and forecasted epidemiology, as well as the Blepharitis market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Explore the intricate details of the Blepharitis Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Blepharitis Market Forecast @ https://www.delveinsight.com/sample-request/blepharitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from…
CAR-T in NHL Treatment Market Size is estimated to grow by 2034, estimates Delve …
DelveInsight's "CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of CAR T-Cell Therapy for Non-Hodgkin's Lymphoma, historical and forecasted epidemiology, as well as the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Explore the intricate details of the CAR T-Cell Therapy for Non-Hodgkin's Lymphoma…
More Releases for Bronchitis
Bronchitis Market Key Players, Trends & Forecast to 2034
The Bronchitis Market is expanding steadily as global respiratory infections increase and healthcare systems adopt more effective inhalation therapies, diagnostics, and preventive care strategies. With advancements in chronic bronchitis treatment, growing COPD prevalence, and rising air pollution levels, the market is poised for strong growth through 2034.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/52006
1. What Is Bronchitis? (Keyword Definition)
Bronchitis is an inflammation of the bronchial tubes, which carry air…
Rising Respiratory Disease Incidence Sparks Robust Growth In Bronchitis Treatmen …
The Bronchitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Bronchitis Treatment Market?
The market for bronchitis treatments has seen robust expansion in the past few years, with projections showing an increase from $5.61 billion in 2024 to…
Acute Bronchitis Treatment Market: An In-Depth Analysis
The global Acute Bronchitis Treatment market was valued at approximately USD 6.3 billion in 2023 and is projected to reach around USD 9.9 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% during the forecast period.
Acute Bronchitis Treatment Market Overview
Acute bronchitis is a common respiratory condition characterized by inflammation of the bronchial tubes, leading to symptoms such as coughing and mucus production. The market's growth…
Bronchitis Treatment Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Bronchitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Bronchitis Treatment Market Outlook, Insights, Size 2024-2033
The bronchitis treatment market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising air pollution levels, cigarette smoking epidemic, increased respiratory infections, environmental and occupational exposures, lifestyle factors..
The bronchitis treatment market size is expected to see strong…
Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are…
